Evidence map›Paper›PMID 24557701›Full record

Trial reportAJNR. American journal of neuroradiology2014

Impact of age and baseline NIHSS scores on clinical outcomes in the mechanical thrombectomy using solitaire FR in acute ischemic stroke study.

M A Almekhlafi, A Davalos, A Bonafe, R Chapot, J Gralla, V M Pereira, M Goyal, STAR Registry Investigators

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in AJNR. American journal of neuroradiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Review
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 6 countries.

M A AlmekhlafiFrom the Departments of Clinical Neurosciences (M.A.A.)Radiology (M.A.A., M.G.), University of Calgary, Calgary, Alberta, CanadaFaculty of Medicine (M.A.A.), King Abdulaziz University, Jeddah, Saudi Arabia.
A DavalosDepartment of Neurology (A.D.), University Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.
A BonafeDepartment of Neuroradiology (A.B.), Centre Hospitalier Universitaire de Montpellie-Guy de Chauliac, Montpellier, France.
R ChapotDepartment of Neuroradiology (R.C.), Alfred Krupp Krankenhaus, Essen, Germany.
J GrallaDepartment of Diagnostic and Interventional Neuroradiology (J.G.), Inselspital, University of Bern, Bern, Switzerland.
V M PereiraDepartment of Neuroradiology (V.M.P.), University Hospital of Geneva, Geneva, Switzerland.
M GoyalRadiology (M.A.A., M.G.), University of Calgary, Calgary, Alberta, CanadaDepartment for Radiology (M.G.), Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada. mgoyal@ucalgary.ca.
STAR Registry Investigators
Alfried Krupp Hospital · DEHôpital Gui de Chauliac · FRHospital Universitari Germans Trias i Pujol · ESKing Abdulaziz University · SAUniversity Hospital of Bern · CHUniversity Hospital of Geneva · CHUniversity of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeAge and stroke severity are inversely correlated with the odds of favorable outcome after ischemic stroke. A previously proposed score for Stroke Prognostication Using Age and NIHSS Stroke Scale (SPAN) indicated that SPAN-100-positive patients (ie, age + NIHSS score = 100 or more) do not benefit from IV-tPA. If this finding holds true for endovascular therapy, this score can impact patient selection for such interventions. This study investigated whether a score combining age and NIHSS score can improve patients' selection for endovascular stroke therapy. MATERIALS AND

methodsThe SPAN index was calculated for patients in the prospective Solitaire FR Thrombectomy for Acute Revascularization study: an international single-arm multicenter cohort for anterior circulation stroke treatment by using the Solitaire FR. The proportion with favorable outcome (90-day mRS score ≤2) was compared between SPAN-100-positive versus-negative patients.

resultsOf the 202 patients enrolled, 196 had baseline NIHSS scores. Fifteen (7.7%) patients were SPAN-100-positive. There was no difference in the rate of successful reperfusion (Thrombolysis In Cerebral Infarction 2b or 3) between SPAN-100-positive versus -negative groups (93.3% versus 82.8%, respectively; P = .3). Stroke SPAN-100-positive patients had a significantly lower proportion of favorable clinical outcomes (26.7% versus 60.8% in SPAN-100-negative, P = .01). In a multivariable analysis, SPAN-100-positive status was associated with lower odds of favorable outcome (OR, 0.3; 95% CI, 0.1-0.9; P = .04). A higher baseline Alberta Stroke Program Early CT Score and a short onset to revascularization time also predicted favorable outcome in the multivariable analysis.

conclusionsA significantly lower proportion of patients with a positive SPAN-100 achieved favorable outcome in this cohort. SPAN-100 was an independent predictor of favorable outcome after adjusting for time to treatment and the extent of preintervention tissue damage according to the Alberta Stroke Program Early CT Score.

Indexed as

RegistriesAdolescentAdultAgedAged, 80 and overAge DistributionBrain IschemiaEquipment DesignEquipment Failure AnalysisFemaleHumansInternationalityMaleMechanical ThrombolysisMiddle AgedPrevalence

Identifiers

PMID24557701
PMCPMC7966577
OpenAlexW2114195931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.